Skip to content

Structure Therapeutics

US · GPCR #2815 by market cap Listed 2023
16.13 -0.99 -5.78%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Structure Therapeutics

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Founded
2016
CEO
Professor Raymond C. Stevens, PhD
Employees
220
Headquarters
South San Francisco, California, United States of America
Fiscal year end
12-31
Website
structuretx.com

Company profile

Exchange
US
Symbol
GPCR
Market-cap rank
#2815
Listing date
2023-02-03
Market cap
1.15B
Float cap
894.95M
Shares out
71.59M
Float shares
55.48M

Sectors & themes

Biotechnology Weight Loss Drugs Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Structure Therapeutics discussion 0 comments

Add a comment